HLA-A and small cell lung carcinoma: Single-cell spatial proteomic analysis revealed that both HLA-A and HLA-DR levels were higher in tumor tissues from patients with early-stage SCLC than in those from patients with late-stage SCLC (Fig. 4h, i).